Fatigue, insomnia and nervousness: Gender disparities and roles of individual characteristics and lifestyle factors among economically active people

Social Psychiatry and Psychiatric Epidemiology

Volumn 44, Issue 9, 2009, Pages 703-709

  Peretti Watel, Patrick ^a   Legleye, Stéphane ^a,c   Baumann, Michèle ^d   Choquet, Marie ^a,b   Falissard, Bruno ^a,b,e   Chau, Nearkasen ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Observatoire Français des Drogues et des Toxicomanies OFDT   (France)

^d UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Fatigue; Gender; Individual characteristics; Insomnia; Lifestyle; Nervousness

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; EDUCATION; FAMILY; FATIGUE; FEMALE; FRANCE; HUMAN; INSOMNIA; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANUAL LABOR; MENTAL DISEASE; NERVOUSNESS; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING;

ADOLESCENT; ADULT; ANXIETY; EDUCATIONAL STATUS; FATIGUE; FEMALE; FRANCE; HUMANS; INCOME; LIFE STYLE; MALE; MARITAL STATUS; MIDDLE AGED; OBESITY; OCCUPATIONS; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SMOKING; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 69849111471     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-008-0487-x     Document Type: Article

References (53)

1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martínez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacín C, Romera B, Taub N, Vollebergh WA, ESEMeD/MHEDEA (2000) Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420:21-27
2. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martínez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacín C, Romera B, Taub N, Vollebergh WA, ESEMeD/MHEDEA 2000 investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project (2004) Psychotropic drug utilization in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420:55-64
3. Arwidson P, Guilbert P (2001) Consommation de soins et de médicaments. In: Guilbert P, Baudier F, Gautier A (eds) Baromètre santé 2000. INPES, Vanves, pp 311-324
4. Ashton H (1991) Psychotropic-drug prescribing for women. Br J Psychiatry 158:30-35
5. Baumann M, Pommier J, Deschamps JP (1996) Prescription médicale et consommation de psychotropes: Quelques interrogations sur les différences entre hommes et femmes. Cah Sociol Demogr Med 63-78
6. Baumann M, Spitz E, Guillemin F, Ravaud JF, Choquet M, Falissard B, Chau N, Lorhandicap Group (2007) Associations of social and material deprivation with tobacco, alcohol, and psychotropic drug use, and gender differentials: A population-based study. Int J Health Geogr 6:50-60. doi: 10.1186/1476-072X-6-50
7. Baumann M, Spitz E, Predine R, Choquet M, Chau N (2007) Do male and female adolescents differ in the effect of individual and family characteristics on their use of psychotropic drugs? Eur J Pediatr 166:29-35
8. Beresford TP, Blow FC, Hill E, Singer K, Lucey MR (1990) Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet 336:482-485
9. Bhattacherjee A, Chau N, Sierra CO, Legras B, Benamghar L, Michaely JP, Ghosh AK, Guillemin F, Ravaud JF, Mur JM (2003) Relationships of job and some individual characteristics to occupational injuries in employed people: A community-based study. J Occup Health 45:382-391
10. Blaska B (1990) The myriad medication mistakes in psychiatry: A consumer's view. Hosp Community Psychiatry 41:993-998
11. Cafferata GL, Kasper J, Bernstein A (1983) Family roles, structure, and stressors in relation to sex differences in obtaining psychotropic drugs. J Health Soc Behav 24:132-143
12. Cafferata GL, Meyers SM (1990) Pathways to psychotropic drugs. Understanding the basis of gender differences. Med Care 28:285-300
13. Challier B, Chau N, Predine R, Choquet M, Legras B (2000) Associations of family environment and individual factors with tobacco, alcohol, and illicit drug use in adolescents. Eur J Epidemiol 16:33-42
14. Chambers CD, Griffey MS (1975) Use of legal substances within the general population: The sex and age variables. Addict Dis 2:7-19
15. Chau N, Baumann M, Falissard B, Choquet M, the Lorhandicap group (2008) Social inequalities and correlates of psychotropic drug use among young adults: A population-based study. Int J Equity Health 7:3-14. doi: 10.1186/14759276-7-3
16. Chau N, Ravaud JF, Otero-Sierra C, Legras B, Macho-Fernandez J, Guillemin F, Sanchez J, Mur JM (2005) Prevalence of impairments and social inequalities: A community-based study in Lorraine. Revue d'Epidemiologie et de Sante Publique 53:614-628
17. Chau N, Bourgkard E, Bhattacherjee A, Ravaud JF, Choquet M, Mur JM, Lorhandicap group (2008) Associations of job, living conditions and lifestyle with occupational injuries in working population: A population-based study. Int Arch Occup Environ Health 81:379-389
18. Chellappa SL, Araújo JF (2007) Sleep disorders and suicidal ideation in patients with depressive disorder. Psychiatry Res 153:131-136
19. Cooperstock R (1978) Sex differences in psychotropic drugs use: A review of findings and methods. Soc Sci Med 12:179-186
20. Cooperstock R, Lennard H (1979) Some social meanings of tranquiliser use. Social Health Illn 1:331-347
21. Etter JF, Perneger TV (1997) Analysis of non-response bias in a mailed health survey. J Clin Epidemiol 50:1123-1128
22. Ferrie JE, Shipley MJ, Cappuccio FP, Brunner E, Miller MA, Kumari M, Marmot MG (2007) A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 30:1659-1666
23. Gabe J, Thorogood M (1986) Prescribed drug use and the management of everyday life: The experiences of black and white working class women. Soc Rev 34:737-772
24. Gasquet I, Nègre-Pagès L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, Lépine JP (2005) Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study. Encephale 31:195-206
25. Gauchard GC, Deviterne D, Guillemin F, Sanchez J, Perrin PP, Mur JM, Ravaud JF, Chau N (2006) Prevalence of sensory and cognitive disabilities and falls, and their relationships: A community-based study. Neuroepidemiol 26:108-118
26. Guilbert P, Baudier F, Gautier A (2001) Baromètre santé 2000 - Résultats, vol 2. CFES, Vanves
27. Guillemin F, Paul-Dauphin A, Virion JM, Bouchet C, Briançon S (1997) The DUKE health profile: A generic instrument to measure the quality of life tied to health. Sante Publique 9:35-44
28. Gustafsson TM, Isacson DGL, Thorslund M, Sorbom D (1996) Factors associated with psychotropic drug use among the elderly living at home. J Appl Gerontol 15:238-254
29. Hartz AJ, Daly JM, Kohatsu ND, Stromquist AM, Jogerst GJ, Kukoyi OA (2007) Risk factors for insomnia in a rural population. Ann Epidemiol 17:940-947
30. Hendricks J, Johnson TP, Sheahan SL, Coons SJ (1991) Medication among older persons in congregate living facilities. J Geriatr Drug Ther 6:47-61
31. Institut national de prévention et d'éducation pour la santé. Baromètre santé 2000. http://www.inpes.sante.fr/index.asp?page=Barometres/Baro2000/Integral/ inegalites/1.asp. Accessed 10 Mar 2008
32. Institut national de la statistique et des études économiques (1993) Recensement de la population de 1990. Sondage au 1/4. INSEE, Nancy
33. Kant IJ, Bultmann U, Schroer KA, Beurskens AJ, Van Amelsvoort LG, Swaen GM (2003) An epidemiological approach to study fatigue in the working population: The Maastricht Cohort Study. Occup Environ Med 60:i32-i39
34. Khlat M, Ravaud JF, Brouard N, Chau N, Group Lorhandicap (2008) Occupational disparities in accidents and roles of lifestyle factors and disabilities. A population-based study in North-eastern France. Public Health 122:771-783
35. Lorhandicap-group (2000) Approches méthodologiques dans une enquête épidémiologique sur les handicaps en Lorraine. Handicap Revue de Sciences Humaines et Sociales 88:1-23
36. Lorhandicap group, Chau N, Ravaud JF, Bourgkard E, Sanchez J, Choquet M, Meyer JP, Otero Sierra C, Michaely JP, Legras B, Guillemin F, Bhattacherjee A, Guillaume S, Dazord A, Méjean L, Tubiana-Rufi N, Schléret Y, Mur JM (2004) Relationships of demanding work conditions with fatigue and psychosomatic disorders: A community-based study. Occup Environ Med 61:e46-e46
37. Lovell A, Fuhrer R (1996) Troubles de la santé mentale: La plus grande "fragilité" des femmes remise en cause. In: Savrel-Cubizolles MJ, Blondel B (eds) La santé des femmes. Flammarion, Paris, pp 252-283
38. Marquié L, Raufaste E, Lauque D, Mariné C, Ecoiffier M, Sorum P (2003) Pain rating by patients and physicians: Evidence of systematic pain miscalibration. Pain 102:289-296
39. Martens EJ, Nyklíček I, Szabó BM, Kupper N (2008) Depression and anxiety as predictors of heart rate variability after myocardial infarction. Psychol Med 38:375-383
40. Martin R, Lemos K (2002) From heart attacks to melanoma: Do common sense models of somatization influence symptom interpretation for female victims? Health Psychol 21:25-32
41. Nakata A, Haratani T, Takahashi M, Kawakami N, Arito H, Kobayashi F, Fujioka Y, Fukui S, Araki S (2004) Association of sickness absence with poor sleep and depressive symptoms in shift workers. Chronobiol Int 21:899-912
42. Ohayon MM, Lader MH (2002) Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63:817-825
43. Olié JP, Elomari F, Spadone C, Lépine JP (2002) Antidepressants consumption in the global population in France. Encephale 28:411-417
44. Rueff B (1995) Les malades de l'alcool. John Libbey Eurotext, Paris
45. Rusli BN, Edimansyah BA, Naing L (2008) Working conditions, self-perceived stress, anxiety, depression and quality of life: A structural equation modelling approach. BMC Public Health 8:48 (doi: 10.1186/1471-2458-8-48)
46. 0Spagnoli A, Ostino G, Borga AD, D'Ambrosio R, Maggiorotti P, Todisco E, Prattichizzo W, Pia L, Comelli M (1989) Drug compliance and unreported drugs in the elderly. J Am Geriatr Soc 37:619-624
47. Suka M, Yoshida K, Sugimori H (2003) Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health 45:344-350
48. Székely A, Balog P, Benkö E, Breuer T, Székely J, Kertai MD, Horkay F, Kopp MS, Thayer JF (2007) Anxiety predicts mortality and morbidity after coronary artery and valve surgery - a 4-year follow-up study. Psychosom Med 69:625-631
49. Tarasiuk A, Greenberg-Dotan S, Simon-Tuval T, Oksenberg A, Reuveni H (2008) The effect of obstructive sleep apnea on morbidity and health care utilization of middle-aged and older adults. J Am Geriatr Soc 56:247-254
50. Tsara V, Kaimakamis E, Serasli E, Katsarou Z, Christaki P (2008) Health related quality of life in Greek patients with sleep apnea-hypopnea syndrome treated with continuous positive airway pressure. Sleep Med Feb 14 (Epub ahead of print)
51. Verbrugge LM, Steiner RP (1985) Prescribing drugs to men and women. Health Psychol 4:79-98
52. Wallander MA, Johansson S, Ruigómez A, García Rodríguez LA, Jones R (2007) Morbidity associated with sleep disorders in primary care: A longitudinal cohort study. Prim Care Companion J Clin Psychiatry 9:338-345
53. World Health Organization (2000) Obesity: Preventing and managing the global epidemic. WHO obesity technical report series no. 894. World Health Organization, Geneva